Skip to content

DEHOUCK

Active Risk: not assessed Private limited companyfounded 2004active for 21 yearsZandvoordestraat 41, 8400 OstendKBO/BCE: BE 0870.521.847

Timeline

34 events since 2004

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed PDFabbreviated format · 100 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0870521847
Annual accounts 2024 filed PDFabbreviated format · 1 day before the deadline
2024
Liquidity more than triples current ratio 2.40 The current ratio rises from 0.69 to 2.40. Short-term debt falls from €1.8m to €543,189.
Annual accounts 2023 filed PDFabbreviated format · 22 days before the deadline
2023
Resignation: (director)Director discharge: · General meeting of 01-10-20233 points ▸
  • General meeting, 01-10-2023
  • Director resignation,
  • Director discharge,

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFabbreviated format · 77 days before the deadline
2022
Back to profit net €53,878 The net result is €53,878, after one loss-making year.
Annual accounts 2021 filed PDFabbreviated format · 12 days before the deadline
2021
Weakest financial year net -€13,085 The net result drops to -€13,085, the lowest from 2007 to 2025. It recovers the following year.
Company renamed from Pharma Dehouck to DehouckResignations: (statutory director), (director) and (director) · Reappointments: (statutory director), (director) and (director) · “Het oprichten,het overnemen en uitbaten van een of meerdere apotheken met alle hieronder begrepen activiteiten…” (deed in Dutch) · General meeting of 20-09-202114 points ▸
  • General meeting, 20-09-2021
  • Purpose change, “Het oprichten,het overnemen en uitbaten van een of meerdere apotheken met alle hieronder begrepen activiteiten en onder meer de handel onder alle vormen,aankoop…” (deed in Dutch)
  • Name change, Dehouck
  • Director resignation, (statutory director)
  • Director resignation, (director (not named in the articles))
  • Director resignation, (director (not named in the articles))
  • Director reappointment, (statutory director)
  • Director reappointment, (director (not named in the articles))
  • Director reappointment, (director (not named in the articles))
  • 100 shares
  • Board composition, (statutory director)
  • Registered office clause, Zandvoordestraat 41
  • Power of attorney,
  • Director discharge,
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2020 filed PDFabbreviated format · 12 days before the deadline
2020
Highest result from 2007 to 2025 net €241,056 ▲129% The net result of €241,056 is the highest of those years.
Annual accounts 2019 filed PDFabbreviated format · 32 days before the deadline
2019
Liquidity more than 7 times current ratio 1.39 The current ratio rises from 0.19 to 1.39. Short-term debt falls from €1.8m to €351,578.
Annual accounts 2018 filed PDFabbreviated format · 12 days before the deadline
2018
Appointment: (manager)General meeting of 01-10-20182 points ▸
  • General meeting, 01-10-2018
  • Director appointment, (manager)

Open the deed in the Belgian Official Gazette

Capital decrease of €360,000 to €312,000Capital from €672,000 to €312,000 · General meeting of 27-09-20185 points ▸
  • General meeting, 27-09-2018
  • Capital decrease, €360,000
  • Capital, €312,000, 100 shares
  • Amendment of the articles, article 5
  • Power of attorney,
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2017 filed PDFabbreviated format · 15 days before the deadline
2017
Annual accounts 2016 filed PDFmicro format · 13 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 3 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 11 days before the deadline
2014
Equity above €1m equity €1.0m ▲84.6% Equity rises from €565,449 to €1.0m.
Annual accounts 2013 filed PDFabbreviated format · 27 days before the deadline
2013
Annual accounts 2012 filed PDFabbreviated format · 12 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 22 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 33 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 40 days before the deadline
2009
Equity above €500,000 equity €620,727 ▲62% With a profit in every financial year since 2007, equity grows to €620,727.
2008
Annual accounts 2008 filed PDFabbreviated format · 39 days before the deadline
2007
Annual accounts 2007 filed PDFabbreviated format · 2 days before the deadline
2006
Annual accounts 2006 filed PDFabbreviated format · 20 days before the deadline
2004
Incorporation PDFpublished on 23-12-2004
First establishment Pharma Dehouck, Zandvoordestraat 41, Ostend

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 13 December 2004, DEHOUCK was incorporated.1 Since 2021 the company has been called Dehouck.2 Total assets went from €4.4m in 2018 to €3.8m in 2025 and headcount from 0.7 to 0.3 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-10-2021
  3. 3National Bank, annual accounts 2018 and 2025

Next steps